Structural Basis of Extended Spectrum TEM
-Lactamases
CRYSTALLOGRAPHIC, KINETIC, AND MASS SPECTROMETRIC INVESTIGATIONS OF ENZYME MUTANTS (*)
- Laurent Maveyraud(1)(§),
- Isabelle Saves(§),(2),
- Odile Burlet-Schiltz(§),(3),
- Peter Swarén(1),
- Jean-Michel Masson(2),
- Myriam Delaire(2),
- Lionel Mourey(1),
- Jean-Claude Promé(3) and
- Jean-Pierre Samama(1)(¶)
- From the (1)Groupe de Cristallographie Biologique,
- (2)Groupe d'Ingéniérie des Protéines, and
- (3)Groupe de Spectrométrie de Masse du Laboratoire de Pharmacologie et de Toxicologie Fondamentales, 205 route de Narbonne, 31 077 Toulouse Cedex, France
- ↵¶ To whom correspondence should be addressed: Groupe de Cristallographie Biologique du LPTF, CEMES-CNRS, BP 4347, 29 rue Jeanne Marvig, 31 055 Toulouse Cedex, France. Tel.: 33 62 25 78 08; Fax: 33 62 25 79 60; samama{at}ecstasy.cemes.fr.
Abstract
The E166Y and the E166Y/R164S TEM-1 β-lactamase mutant enzymes display extended spectrum substrate specificities. Electrospray
mass spectrometry demonstrates that, with penicillin G as substrate, the rate-limiting step in catalysis is the hydrolysis
of the E166Y acyl-enzyme complex. Comparison of the 1.8-Å resolution x-ray structures of the wild-type and of the E166Y mutant
enzymes shows that the binding of cephalosporin substrates is improved, in the mutant enzyme, by the enlargement of the substrate
binding site. This enlargement is due to the rigid body displacement of 60 residues driven by the movement of the
-loop. These structural observations strongly suggest that the link between the position of the
-loop and that of helix H5, plays a central role in the structural events leading to extended spectrum TEM-related enzymes.
The increased
-loop flexibility caused by the R164S mutation, which is found in several natural mutant TEM enzymes, may lead to similar
structural effects. Comparison of the kinetic data of the E166Y, E166Y/R164S, and R164S mutant enzymes supports this hypothesis.
Footnotes
-
↵§ These authors contributed equally to this work.
-
↵* This work was supported, in part, by the Institut National de la Santé et de la Recherche Médicale (Contract 930612) and by Association pour la Recherche contre le Cancer (Contract 6564). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- Received July 31, 1995.
- Revision received January 16, 1996.
- © 1996 by The American Society for Biochemistry and Molecular Biology, Inc.











